Ellie Simmonds, Paralympic Champion, Receives Honorary Degree From Swansea University
https://pixabay.com/en/gold-medal-winner-swimming-381749/

Ellie Simmonds, Paralympic Champion, Receives Honorary Degree From Swansea University

Ellie Simmonds is a dominate Paralympic swimmer having won five times in her 23-years and was honored locally for her success, reported Border Telegraph.  Just recently, she attended to a…

Continue Reading Ellie Simmonds, Paralympic Champion, Receives Honorary Degree From Swansea University
Midatech Pharma Gets Verbal Approval For MTD201 Continued Development
Source: Pixabay

Midatech Pharma Gets Verbal Approval For MTD201 Continued Development

Midatech Pharma just received verbal confirmation from Polish regulators to conduct the first European in-human study for a treatment that could potential aid those with carcinoid cancer and acromegaly, reported…

Continue Reading Midatech Pharma Gets Verbal Approval For MTD201 Continued Development
PharmaCare in British Columbia Refuses to Cover Medication for Juvenile Idiopathic Arthritis
source: pixabay.com

PharmaCare in British Columbia Refuses to Cover Medication for Juvenile Idiopathic Arthritis

According to a story from CBC News, Jillian Lanthier's son Landen Alexa was diagnosed with a severe and rare form of juvenile idiopathic arthritis at six years old. Although he…

Continue Reading PharmaCare in British Columbia Refuses to Cover Medication for Juvenile Idiopathic Arthritis
A Conditional Application for a New Vasculitis Treatment Was Just Accepted By The EMA
source: pixabay.com

A Conditional Application for a New Vasculitis Treatment Was Just Accepted By The EMA

According to a story from ANCA Vasculitis News, The European Medicines Agency just approved the pharmaceutical company ChemoCentryx's application for the marketing of avacopan as a potential treatment for anti-neutrophil…

Continue Reading A Conditional Application for a New Vasculitis Treatment Was Just Accepted By The EMA
CureVac Partners with Arcturus Therapeutics to Target Ornithine Transcarbamylase Deficiency
Source: Pixabay

CureVac Partners with Arcturus Therapeutics to Target Ornithine Transcarbamylase Deficiency

Another successful partnership in the rare disease community has come to fruition, reports The Pharma Letter. Just this past week, CureVac and Arcturus Therapeutics will become a powerhouse together with…

Continue Reading CureVac Partners with Arcturus Therapeutics to Target Ornithine Transcarbamylase Deficiency
This Experimental Drug Just Received Orphan Drug Designation For Congenital Adrenal Hyperplasia
source: pixabay.com

This Experimental Drug Just Received Orphan Drug Designation For Congenital Adrenal Hyperplasia

According to a story from prnewswire.com, the experimental treatment SPR001 was just granted orphan drug status by the Food and Drug Administration (FDA). The new treatment is currently being developed…

Continue Reading This Experimental Drug Just Received Orphan Drug Designation For Congenital Adrenal Hyperplasia
Cycle Pharmaceuticals Partners With US-Firm To Utilize 3D Printing Technology For Rare Disease Treatment Development
Source: Pixabay

Cycle Pharmaceuticals Partners With US-Firm To Utilize 3D Printing Technology For Rare Disease Treatment Development

Cycle Pharmaceuticals shook hands with US-based firm, Aprecia Pharmaceuticals as they agreed to develop and commercialize treatments for rare diseases using the advanced technology of 3D printing, recently reported Cambridge…

Continue Reading Cycle Pharmaceuticals Partners With US-Firm To Utilize 3D Printing Technology For Rare Disease Treatment Development
Bioprinted Liver Tissue Could Help Treat A1AD, And it Just Got Orphan Drug Status
Source: Pixabay

Bioprinted Liver Tissue Could Help Treat A1AD, And it Just Got Orphan Drug Status

Organovo Holdings recently stated that its 3D bioprinted therapeutic liver tissue was granted orphan drug status by the Food and Drug Administration (FDA). Taylor Crouch, the company CEO, was excited…

Continue Reading Bioprinted Liver Tissue Could Help Treat A1AD, And it Just Got Orphan Drug Status
Aspiring Physician Assistant with Keratoconus Avoids Blindness with Experimental Cross-Linking Procedure
Source: Pixabay

Aspiring Physician Assistant with Keratoconus Avoids Blindness with Experimental Cross-Linking Procedure

In 2009 Emily Rochac Argueta realized her vision was rapidly deteriorating headed towards blindness, reported Times Union. The aspiring physician assistant was diagnosed with keratoconus, a rare eye disease that…

Continue Reading Aspiring Physician Assistant with Keratoconus Avoids Blindness with Experimental Cross-Linking Procedure